328 related articles for article (PubMed ID: 31672982)
1. Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma.
Fattore L; Ruggiero CF; Liguoro D; Mancini R; Ciliberto G
Cell Death Dis; 2019 Oct; 10(11):827. PubMed ID: 31672982
[TBL] [Abstract][Full Text] [Related]
2. Intra-tumour heterogeneity - going beyond genetics.
Caiado F; Silva-Santos B; Norell H
FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis.
Motwani J; Eccles MR
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680938
[TBL] [Abstract][Full Text] [Related]
4. Unravelling Tumour Microenvironment in Melanoma at Single-Cell Level and Challenges to Checkpoint Immunotherapy.
Bai X; Quek C
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292642
[TBL] [Abstract][Full Text] [Related]
5. Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.
Melchardt T; Magnes T; Hufnagl C; Thorner AR; Ducar M; Neureiter D; Tränkenschuh W; Klieser E; Gaggl A; Rösch S; Rasp G; Hartmann TN; Pleyer L; Rinnerthaler G; Weiss L; Greil R; Egle A
Eur J Cancer; 2018 Apr; 93():69-78. PubMed ID: 29477794
[TBL] [Abstract][Full Text] [Related]
6. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
[TBL] [Abstract][Full Text] [Related]
7. High-Dimensional Single-Cell Transcriptomics in Melanoma and Cancer Immunotherapy.
Quek C; Bai X; Long GV; Scolyer RA; Wilmott JS
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681023
[TBL] [Abstract][Full Text] [Related]
8. Tumor Heterogeneity in Pancreatic Adenocarcinoma.
Cros J; Raffenne J; Couvelard A; Poté N
Pathobiology; 2018; 85(1-2):64-71. PubMed ID: 28787741
[TBL] [Abstract][Full Text] [Related]
9. Single Cell Genomics for Tumor Heterogeneity.
Lee HO; Park WY
Adv Exp Med Biol; 2021; 1187():205-214. PubMed ID: 33983580
[TBL] [Abstract][Full Text] [Related]
10. Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.
Gerber T; Willscher E; Loeffler-Wirth H; Hopp L; Schadendorf D; Schartl M; Anderegg U; Camp G; Treutlein B; Binder H; Kunz M
Oncotarget; 2017 Jan; 8(1):846-862. PubMed ID: 27903987
[TBL] [Abstract][Full Text] [Related]
11. Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma.
Roesch A
Oncogene; 2015 Jun; 34(23):2951-7. PubMed ID: 25109330
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell RNA-Seq Reveals Melanoma Transcriptional Heterogeneity.
Cancer Discov; 2016 Jun; 6(6):570. PubMed ID: 27102072
[TBL] [Abstract][Full Text] [Related]
13. Genetic and non-genetic clonal diversity in cancer evolution.
Black JRM; McGranahan N
Nat Rev Cancer; 2021 Jun; 21(6):379-392. PubMed ID: 33727690
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression.
Lüönd F; Tiede S; Christofori G
Br J Cancer; 2021 Jul; 125(2):164-175. PubMed ID: 33824479
[TBL] [Abstract][Full Text] [Related]
15. Tumour heterogeneity and metastasis at single-cell resolution.
Lawson DA; Kessenbrock K; Davis RT; Pervolarakis N; Werb Z
Nat Cell Biol; 2018 Dec; 20(12):1349-1360. PubMed ID: 30482943
[TBL] [Abstract][Full Text] [Related]
16. Tumour heterogeneity and resistance to cancer therapies.
Dagogo-Jack I; Shaw AT
Nat Rev Clin Oncol; 2018 Feb; 15(2):81-94. PubMed ID: 29115304
[TBL] [Abstract][Full Text] [Related]
17. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome.
Caswell DR; Swanton C
BMC Med; 2017 Jul; 15(1):133. PubMed ID: 28716075
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma.
Roesch A; Paschen A; Landsberg J; Helfrich I; Becker JC; Schadendorf D
Eur J Cancer; 2016 May; 59():109-112. PubMed ID: 27023049
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma.
Khoja L; Shenjere P; Hodgson C; Hodgetts J; Clack G; Hughes A; Lorigan P; Dive C
Melanoma Res; 2014 Feb; 24(1):40-6. PubMed ID: 24201293
[TBL] [Abstract][Full Text] [Related]
20. Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases.
Rabbie R; Ansari-Pour N; Cast O; Lau D; Scott F; Welsh SJ; Parkinson C; Khoja L; Moore L; Tullett M; Wong K; Ferreira I; Gómez JMM; Levesque M; Gallagher FA; Jiménez-Sánchez A; Riva L; Miller ML; Allinson K; Campbell PJ; Corrie P; Wedge DC; Adams DJ
Nat Commun; 2020 Aug; 11(1):4306. PubMed ID: 32855398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
